Section: Partnerships and Cooperations

International Initiatives

Inria Associate Teams Not Involved in an Inria International Labs

Compasso

• Title: COMmunity Perspective in the health sciences: Algorithms and Statistical approacheS for explOring it

• Duration: 2018, renewable from 2 to 5 years more

• Coordinator: On the Portuguese side, Susana Vinga, IST, Lisbon, Portugal; on the French side, Marie-France Sagot

• ERABLE participant(s): R. Andrade, M. Ferrarini, G. Italiano, A. Marchetti-Spaccamela, A. Mary, H. T. Pusa, M.-F. Sagot, B. Sinaimeri, L. Stougie, A. Viari, I. Ziska

• Web page: http://team.inria.fr/erable/en/projects/inria-associated-team-compasso/

Participation in International Programs

ERABLE is coordinator of a CNRS-UCBL-Inria Laboratoire International Associé (LIA) with the Laboratório Nacional de Computação Científica (LNCC), Petrópolis, Brazil. The LIA has for acronym LIRIO (“Laboratoire International de Recherche en bIOinformatique”) and is coordinated by Ana Tereza Vasconcelos from the LNCC and Marie-France Sagot from BAOBAB-ERABLE. The LIA was created in January 2012 for 4 years, renewable once for 4 more years. A web page for the LIA LIRIO is available at this address: http://team.inria.fr/erable/en/cnrs-lia-laboratoire-international-associe-lirio/.

ERABLE also participated to the BASIS project. This was funded by the European Community Seventh Framework Programme (Grant 242006 - 2010-2015). It was led by Dr. Mike Stratton and involved six European countries. It was primarily focused on ER+/HER2- breast cancers, but during the course of the project, was merged with the HER2+ French-ICGC and triple negative UK-ICGC projects, resulting in the analysis of the whole spectrum of breast cancers. The French group was initiated by Dr. Gilles Thomas and was pursued by Alain Viari after the loss of Dr. Thomas in 2014. The project resulted in the sequencing and thorough analysis of 560 breast cancer whole genomes (Nik-Zainai et al., Nature, 534:47-54, 2016), including 75 HER2+ performed by the French working group (Ferrari et al., Nature Communications, 7, 2016) and funded by the Institut National du Cancer and by Inserm.

Finally, Marie-France Sagot participates in a Portuguese FCT project, Perseids for “Personalizing cancer therapy through integrated modeling and decision” (2016-2019), with Susana Vinga and a number of other Portuguese researchers. The budget of Perseids is managed exclusively by the other Portuguese partner.